A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma - Trial NCT06337266
Access comprehensive clinical trial information for NCT06337266 through Pure Global AI's free database. This phase not specified trial is sponsored by Fujian Medical University and is currently Completed. The study focuses on Gastric Cancer. Target enrollment is 3622 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Fujian Medical University
Timeline & Enrollment
N/A
Jan 01, 2023
Mar 19, 2024
Primary Outcome
5-year OS,5-year DFS
Summary
This study aimed to develop a novel Prognostic Oxidative Stress-Immune-Inflammatory Score
 (POSII Score) and introduce an innovative online calculator designed to predict long-term
 survival and assess the recurrence risk of gastric cancer (GC).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06337266
Non-Device Trial